Results 1 to 10 of about 17,787 (263)
Morphea Induced by Golimumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review [PDF]
Clinical Case ReportsMorphea is a localized autoimmune fibrosing disorder that may paradoxically develop during anti‐TNFα agents in ankylosing spondylitis (AS). We report a second case of morphea associated with long‐term golimumab use in a patient with AS, presenting with ...
Faten Hilwanjee +3 more
doaj +2 more sources
First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?
JMIR Cancer, 2021 Cutaneous melanoma has always been a dreaded diagnosis because of its high mortality rate and its proclivity for invasiveness and metastasis.
Louay S Abdulkarim, Richard J Motley
doaj +1 more source
Anais da Academia Brasileira de Ciências, 2022 Objective was evaluated the therapeutic effect of Juglans regia (J) and Zingiber officinale (Z) extracts, alone or associated (Z75% + J25%, Z50% + J50% and Z25% + J75%) applied on planktonic cultures and biofilms of Propionibacterium acnes ...
LEONARDO A. DA SILVA +7 more
doaj +1 more source
Novel antiangiogenic agents in dermatology [PDF]
Archives of Biochemistry and Biophysics, 2011 Because angiogenesis underlies the pathogenesis of numerous conditions (cancer, psoriasis, macular degeneration), there is a pressing need for continued investigations into angiogenic signaling and potential drug targets. Antiangiogenic agents can be classified as either direct or indirect.
Ricardo L, Berrios, Jack L, Arbiser
openaire +2 more sources
Common Dermatologic Disorders in Down Syndrome: Systematic Review
JMIR Dermatology, 2022 BackgroundDown syndrome (DS) has been associated with cardiovascular, gastrointestinal, and immune-related abnormalities. Several dermatologic conditions, including hidradenitis suppurativa, have also been found to be associated ...
Megan Lam +4 more
doaj +1 more source
Intralesional agents in dermatology: Pros and cons
Journal of Cutaneous and Aesthetic Surgery, 2021 Since introduced in 1961, intralesional (IL) agent has become an essential part of the dermatological practice. The term IL referred to the direct delivery of agent percutaneously into skin lesions. This therapeutic approach is relatively safe, easy to perform and applicable for a broad range of dermatological conditions.
Sakhiya, Jagdish +7 more
openaire +2 more sources
Acta Dermato-Venereologica, 2023 Although isotretinoin has anti-inflammatory and immunomodulatory properties, it can exacerbate atopic dermatitis. National estimates of the extent to which patients with atopic dermatitis are affected by severe acne and isotretinoin tolerability are ...
Cathrine H. Mohn +4 more
doaj +1 more source
Achieving hemostasis in dermatology-Part II: Topical hemostatic agents
Indian Dermatology Online Journal, 2013 Bleeding is a common occurrence during any dermatologic surgery that disrupts blood vessels. The complications of excess bleeding can include delayed wound healing, hematoma formation, infection, dehiscence, and necrosis.
Jaimie B Glick +2 more
doaj +1 more source
Use of psychiatric drugs in Dermatology, [PDF]
Anais Brasileiros de Dermatologia, 2020 Patients with psychocutaneous disorders often refuse psychiatric intervention in their first consultations, leaving initial management to the dermatologist.
Magda Blessmann Weber +2 more
doaj +1 more source
Risperidone-induced erythema multiforme minor
Indian Journal of Psychological Medicine, 2017 Antipsychotic agents are known to cause adverse cutaneous reactions. These are supposedly rare with atypical antipsychotic agents. Adverse dermatologic reactions due to antipsychotic agent risperidone are rarely reported.
Shreyas Shrikant Pendharkar +3 more
doaj +1 more source